93 7219 (Topiramate 100 mg)
Pill imprint 93 7219 has been identified as Topiramate 100 mg.
Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; bulimia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 93 7219
- Strength:
- 100 mg
- Color:
- Yellow
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7219
- Inactive Ingredients:
- silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
hypromelloses
polydextrose
ferric oxide yellow
ferrosoferric oxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68071-0813 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about topiramate
Consumer resources
- Topiramate
- Topiramate extended-release capsules
- Topiramate sprinkle capsules
- Topiramate (Advanced Reading)
- Other brands: Topamax, Trokendi XR, Topiragen, Topamax Sprinkle, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
